Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Are GLP-1 Drug Holidays a Risk Worth Taking?
MedPage Today December 8, 2024
— Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care
In part three of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Karl Nadolsky, DO, and Fatima Cody Stanford, MD, MPH, MPA, MBA, explore the concept of GLP-1 drug holidays, the challenges of maintaining cardiometabolic benefits, and the evolving landscape of obesity care.
Nadolsky is a clinical endocrinologist and obesity specialist at Holland Hospital in Michigan. Stanford is an associate professor of medicine and pediatrics at Massachusetts General Hospital and Harvard Medical School in Boston.
Click here to watch part one and part two.
Following is a partial transcript of the video (note that errors are possible):
Faust: I do want to...
Today's Sponsors
Today's Sponsor